Clinical trial

Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating…

NCT00002842 · City of Hope Medical Center, Other · Completed

Key facts

NCT number NCT00002842
Title Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer
Official title Hepatic Resection Followed by Concurrent Adjuvant Portal Vein Infusion of Fluorodeoxyuridine and Systemic 5-Fluorouracil and Folinic Acid for Metastatic Colorectal Carcinoma
Lead sponsor City of Hope Medical Center, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Colorectal Cancer, Metastatic Cancer
Intervention type Drug, Procedure
Interventions floxuridine, fluorouracil, leucovorin calcium, adjuvant therapy, conventional surgery
Enrollment 49
Start date Sep 1, 1994
Primary completion May 1, 2014
Completion May 1, 2014
First posted Jan 27, 2003
Last update posted Apr 11, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies